Elisa Agostinetto: Risk-reducing surgeries improve survival of young patients with a BRCA mutation and breast cancer
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn:
“Risk-reducing surgeries improve survival of young patients with a BRCA mutation and breast cancer. Happy to share this important work from our BRCA BCY collaborative group now out in the Lancet Oncology
50-days free access link.”
Title: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study
Journal: The Lancet Oncology
Authors: Eva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, Raphaëlle Bas, Hee J Kim, Maria A Franzoi, Rinat Bernstein-Molho, Sabine Linn, Ava Kwong, Katarzyna Pogoda, Judith Balmana, Ann Smeets, Jyoti Bajpai, Halle C F Moore, Ann H Partridge, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Fedro A Peccatori, Tiphaine Renaud, Matteo Lambertini
More posts featuring Elisa Agostinetto.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023